The FDA and other competent authorities are our collaborators.
However, we have a natural tendency to view regulators as adversaries, but with today’s research initiatives in software as a medical device (SaMD), AI, and in silico techniques, meeting with the FDA early is always a good idea to set a successful course for your product roadmap and clinical evidence program.
In this webinar we will go over the various types of meetings and how they can help you with:
Preparing for and conducting investor pitches,
Building the right foundational strategies for success.